Categories
· Health/Science
· Business (Tobacco)
· Lung Cancer
· Philanthropy/Funding
Organizations
· Liggett
|
Jump to full article: New England Journal of Medicine, 2008-04-02
Author: Cornell Research Foundation and licensed to General Electric
Intro: Survival of Patients with Stage I Lung Cancer Detected on CT Screening (October 26, 2006;355:1763-71). The disclosure statement (page 1769) should have read as follows: "Drs. Henschke and Yankelevitz report receiving royalties from Cornell Research Foundation as inventors of methods to assess tumor growth and regression on imaging tests for which pending patents are held by Cornell Research Foundation and licensed to General Electric. No other potential conflict of interest relevant to this article was reported."
Jump to full article » |